Latest news
Loading news…
Serotiny
ClosedOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 MediumHeat score — how much recent activity & attention the company has (web traffic, news, hiring). San Francisco, California, United States Founded 2014 11-50 employees For Profit
Serotiny is an AI-based platform that invents multi-domain therapeutic proteins for CAR T-cell therapies.
Serotiny was acquired by Johnson & Johnson in 2024.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
12
Patents
2
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 15
- Patents granted
- 2
- Trademarks
- 0
- Top patent class
- Medical Or Veterinary Science; Hygiene
- IT spend
- $9M
Company Info
- Founded
- 2014
- Employees
- 11-50
- Operating status
- Closed
- Company type
- For Profit
- Org types
- company
- Founders
- 2
- News articles
- 5
- HQ
- San Francisco, California, United States
- Region
- San Francisco Bay Area, West Coast, Western US
- Exit date
- Apr 1, 2024
Signals & Scores
- Heat score
- Medium
- Trend (7d)
- -0.3
- Trend (30d)
- -0.6
- Trend (90d)
- 0
- Last leadership hire
- May 23, 2022
12
professional contacts at Serotiny
Contact execs at Serotiny →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Serotiny
Loading news…
FAQs about Serotiny
People who checked this page also checked these
Browse the full Acquirezy directory.